BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 82 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $111,700,000 | +23.0% | 1,430,949 | 0.0% | 2.98% | +92.8% |
| Q2 2018 | $90,837,000 | -27.6% | 1,430,949 | +4.6% | 1.55% | -30.1% |
| Q1 2018 | $125,487,000 | +21.6% | 1,368,449 | 0.0% | 2.21% | +26.4% |
| Q4 2017 | $103,195,000 | +147.3% | 1,368,449 | +128.5% | 1.75% | +154.3% |
| Q3 2017 | $41,722,000 | +41.2% | 598,849 | +2.7% | 0.69% | +51.1% |
| Q2 2017 | $29,553,000 | +0.8% | 583,245 | -20.5% | 0.46% | -19.9% |
| Q1 2017 | $29,322,000 | +116.7% | 733,245 | +52.0% | 0.57% | +88.4% |
| Q4 2016 | $13,533,000 | +167.1% | 482,455 | +182.8% | 0.30% | +193.2% |
| Q3 2016 | $5,067,000 | +378.9% | 170,615 | +226.5% | 0.10% | +281.5% |
| Q2 2016 | $1,058,000 | – | 52,250 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |